Header Logo

Connection

Cynthia Comella to Phenylalanine

This is a "connection" page, showing publications Cynthia Comella has written about Phenylalanine.
Connection Strength

0.194
  1. Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof-of-Concept Trial. Mov Disord. 2021 10; 36(10):2408-2412.
    View in: PubMed
    Score: 0.194
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.